Antibody research is a core function
of modern medicine, pharmaceuticals, and diagnostics. The much-undervalued
issue nobody talks about regarding this research is a combination of business and
scientific efficiencies. You hear a lot about big research budgets, but not
much about the nuts and bolts of practical management and sourcing of research
materials, services, and related subjects.
The bottom line in business and
scientific terms can be defined as follows:
● Researchers need to focus on their
work. The more efficient their sources and suppliers, the more efficient their
research processes will be. “Disruption” isn’t a buzzword in research; it’s a
curse.
● Businesses engaged in research need
very good levels of cost-efficiency. Anyone in research-intensive industries
can tell you that cost bases don’t grow on trees, either, and that the bottom
line can deliver some very hard landings.
● Research is like running a marathon
in both business and scientific terms. In research, however, you may not even
know where the finish line is. You have to keep running until you get there.
Economic efficiencies keep you in the race.
Not surprisingly, science and
business are always on the same page when it comes to sourcing materials and
services. Reliability and good costing of both are the keys to successful
research.
If you’re trying to source top quality
antibodies like sheep anti-EGFR, sheep anti 5-methylcytosin or
rabbit
anti-llama HRP,
the ideal solution is a single source supplier which can also deliver technical
support for your work. The “support factor” can deliver major cost benefits in
several ways. For example - If you need a peptide designed and can get it done
externally, you free up time and resources in-house. Your researchers can
charge ahead with their productive work.